Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Research (NRC) Other financing activities (2016 - 2025)

National Research (NRC) has disclosed Other financing activities for 10 consecutive years, with -$1000.0 as the latest value for Q4 2025.

  • Quarterly Other financing activities fell 120.0% to -$1000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $134000.0 through Dec 2025, up 219.05% year-over-year, with the annual reading at $134000.0 for FY2025, 219.05% up from the prior year.
  • Other financing activities hit -$1000.0 in Q4 2025 for National Research, down from $73000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $92000.0 in Q4 2022 to a low of -$1000.0 in Q4 2025.
  • Historically, Other financing activities has averaged $44666.7 across 3 years, with a median of $49500.0 in 2024.
  • Biggest YoY gain for Other financing activities was 120.0% in 2025; the steepest drop was 120.0% in 2025.
  • Year by year, Other financing activities stood at $92000.0 in 2022, then crashed by 94.57% to $5000.0 in 2024, then crashed by 120.0% to -$1000.0 in 2025.
  • Business Quant data shows Other financing activities for NRC at -$1000.0 in Q4 2025, $73000.0 in Q2 2025, and $62000.0 in Q1 2025.